Valuation Changchun BCHT Biotechnology Co.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2026-01-21			5-day change	1st Jan Change
20.56 ^CNY	+3.58%		+1.08%	+9.01%

11-13	BCHT Biotechnology Gets Nod to Trial Vaccines Against Pertussis, Diphtheria, Tetanus	MT
25-10-30	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	28,321	28,531	22,628	10,387	8,505	8,505
Change	-	0.74%	-20.69%	-54.1%	-18.12%	0%
Enterprise Value (EV)	28,321	28,531	22,628	10,387	8,505	8,505
Change	-	0.74%	-20.69%	-54.1%	-18.12%	0%
P/E ratio	111x	157x	45.3x	43.3x	10.9x	7.16x
PBR	8.29x	8.02x	5.63x	2.46x	-	-
PEG	-2.4x	-5.4x	0x	-0.8x	0x	0.1x
Capitalization / Revenue	23,560,936x	26,628,893x	12,400,908x	8,450,961x	-	-
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	0.15	0.15	0.169	0.19	-
Rate of return	-	0.22%	0.27%	0.67%	0.92%	-
EPS ²	0.62	0.44	1.21	0.58	1.89	2.87
Distribution rate	-	34.1%	12.4%	29.1%	10.1%	-
Net sales	1,202	1,071	1,825	1,229	-	-
EBITDA	331.2	263.5	651.3	371.2	-	-
EBIT	261.9	187	559.3	265.6	-	-
Net income ¹	243.6	181.6	501	238.9	780.4	1,185
Net Debt	-	-	-	-	-	-
Reference price ²	68.60	69.11	54.81	25.11	20.56	20.56
Nbr of stocks (in thousands)	412,841	412,841	412,841	413,658	413,658	413,658
Announcement Date	2/18/22	2/24/23	2/23/24	2/25/25	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHANGCHUN BCHT BIOTECHNOLOGY CO.	10.88x	-	-	0.92%	1.22B
MERCK KGAA	18.49x	2.92x	10.11x	1.87%	63.11B
KYOWA KIRIN CO., LTD.	24.27x	2.37x	10.36x	2.31%	8.58B
HALOZYME THERAPEUTICS, INC.	13.18x	6.82x	10.55x	-	8.43B
SK BIOPHARMACEUTICALS CO., LTD.	51.01x	12.14x	38.28x	-.--%	6.1B
YUHAN CORPORATION	62.28x	3.4x	38.98x	0.48%	5.24B
INDIVIOR PLC	18.74x	3.5x	10.05x	-.--%	4.12B
BETTA PHARMACEUTICALS CO., LTD.	35.95x	6.1x	20.1x	0.74%	2.95B
SUPERNUS PHARMACEUTICALS, INC.	-69.99x	-	-	-	2.84B
Average	18.31x	5.32x	19.78x	0.9%	11.4B
Weighted average by Cap.	20.68x	3.92x	13.75x	1.57%